SCHEMBL4038445

SCHEMBL4038445

CC(C)[C@H](CCC(=O)O)NCc1cc(Oc2ccccc2)ncc1[N+](=O)[O-]

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.36
HPSE Q9Y251 1/20 0.35
XDH P47989 1/20 0.35
ADAMTS4 O75173 1/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP13 P45452 1/20 0.35
MMP14 P50281 1/20 0.35
ADAMTS5 Q9UNA0 1/20 0.35
CYP2C19 P33261 2/20 0.35
GRN P28799 2/20 0.35
SORT1 Q99523 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LTA4H P09960 1/20 0.35
POLB P06746 2/20 0.34
ALDH1A1 P00352 2/20 0.34
FFAR1 O14842 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4038449 1.00 PIN1 (0.36) PIN1HPSEXDHADAMTS4MMP1
SCHEMBL4041803 0.84 LTA4H (0.39) ADAMTS4MMP1MMP2MMP13MMP14
SCHEMBL4041816 0.84 LTA4H (0.39) ADAMTS4MMP1MMP2MMP13MMP14
SCHEMBL1414241 0.83 S1PR1 (0.37) LTA4HPOLBALDH1A1ACACBACACA
SCHEMBL1414469 0.83 S1PR1 (0.37) LTA4HPOLBALDH1A1ACACBACACA
SCHEMBL1414468 0.83 S1PR1 (0.37) LTA4HPOLBALDH1A1ACACBACACA
SCHEMBL1414091 0.81 S1PR1 (0.37) LTA4HACACBACACAMAPT
SCHEMBL1414094 0.81 S1PR1 (0.37) LTA4HACACBACACAMAPT
SCHEMBL4851439 0.78 NPY5R (0.39) LTA4HALDH1A1FFAR1ACACBACACA
SCHEMBL1414510 0.78 NPY5R (0.39) LTA4HALDH1A1FFAR1ACACBACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7531545-B2 2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of β-secretase (BACE) JANSSEN PHARMACEUTICA, N.V. (BE) 2009-05-12 US disclosed
US-20070259898-A1 NOVEL 2-AMINO-3,4-DIHYDRO-PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF beta-SECRETASE (BACE) BAXTER ELLEN E 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259898-A1 NOVEL 2-AMINO-3,4-DIHYDRO-PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF beta-SECRETASE (BACE) BACE2, PSEN2, BACE1 PIN1 3049/4885HPSE 3775/4885XDH 2697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.